1 prophylaxis of opportunistic infections haivn harvard medical school aids initiative in vietnam
TRANSCRIPT
1
Prophylaxis of Opportunistic Infections
HAIVNHarvard Medical School AIDS
Initiative in Vietnam
2
Learning Objectives
By the end of this session, participants should be able to:
Differentiate between primary and secondary prophylaxis
Explain the benefits and indications of cotrimoxazole prophylaxis
Describe the process of cotrimoxazole desensitization
Describe how to provide isoniazid (INH) prophylaxis
3
Relationship Between CD4 Count and Opportunistic Infections
The lower a person’s CD4 count is, the more vulnerable he/she is to opportunistic infections (OIs)
Different infections can occur based on how weak a person’s immune system is
The level of the CD4 count determines the OIs a person is at risk for
4
Sample OIs per CD4 Count
CD4 Count OI / Condition> 500/mm3 Candidal vaginitis
Persistent generalized lymphadenopathy
200-500/mm3 Pneuomoccal pneumoniaPulmonary tuberculosisHerpes zosterOropharyngeal candidiasis (Thrush)
< 200/mm3 Pneumocystis jiroveci pneumoniaMiliary/extrapulmonary TB
< 100/mm3 Candida Esophagitis PenicilliosisToxoplasmosisCryptococcosis
< 50/mm3 Mycobacterium avium complex (MAC)Disseminated cytomegalovirus (CMV)
5
Two Types of OI Prophylaxis
Primary prophylaxis:
Giving medication to prevent an OI from occurring in the first place
Secondary prophylaxis:
Giving medication after an OI is treated to prevent it from recurring
Also known as maintenance therapy
6
Cotrimoxazole Prophylaxis (CTP)
7
Cotrimoxazole (1)
Can prevent: PCP Cerebral toxoplasmosis Malaria Parasitic diarrheas Non-typhoid salmonelloses Streptococcus pneumoniae
pneumonia
8
Cotrimoxazole (2)
Benefits Decreases
morbidity and mortality
Inexpensive Well tolerated Prepares patient
for daily medication taking (adherence)
Concerns Hypersensitivity
(allergic) rash Anemia
The benefits greatly outweigh the risks
9
Cotrimoxazole Allergy (1)
Clinically:• Maculopapular rash • Can have fever• Usually within first few weeks of
treatment Epidemiology• No studies in Asia• In Africa, about 2% had allergy to CTX*
Resolves when drug is stopped* Lancet. 2004 Oct 16-22;364(9443):1428-34.
10
Cotrimoxazole Allergy (2) – How to Manage?
Grade Management I – II • Continue CTX
• Give antihistamines• Follow closely
III • Stop CTX• Consider desensitization or switch to
alternate prophylaxisIV • Stop and do not use CTX again
• Use alternate prophylaxis regimen with dapsone
Vietnam MOH guidelines on treatment of HIV/AIDS, 2009
11
Cotrimoxazole Desensitization
Desensitization is a rechallenge following an adverse reaction starting with low doses and gradually escalating
Review patient daily or give instructions on how to respond to any reaction:
Type of reaction Action
No reaction • Progress to the next stage
Minor reaction • Continue same dose for 1 extra day or until the reaction subsides
• Once reaction subsides: progress to the next stage
Severe, worsening or persistent reaction
• Stop CTX
12
When to Start CTP in Vietnam?
Indications:• CD4 ≤ 350 (any clinical stage)• WHO Stage 3 or 4 regardless of CD4 count• If CD4 testing is not available: clinical stage
2, 3, 4• Pregnant women can use CTX for entire
pregnancy Dose: • Adult: 960 mg/day or 960mg 3x /week• Pediatric: 5 mg/kg/day
13
When to Stop CTP in Vietnam?
No ARV: continue lifelong
With ARV: stop cotrimoxazole when CD4 > 350
14
What Should You Do When You Cannot Use
Cotrimoxazole?
15
Dapsone
Indications: • Prophylaxis of PCP in patients with allergy
or adverse reaction to cotrimoxazole Dose:• Adults: 100 mg daily• Pediatrics: 2 mg/kg once a day
Note: not effective against other OIs Side effects (uncommon): rash,
haemolytic anemia, hepatitis
16
TB Prophylaxis Therapy
17
Isoniazid Preventive Therapy (IPT)
Indication: • PLHIV with negative TB screening
Dose: Isoniazid 300 mg (5 mg/kg) once daily for 9 months
Must exclude active TB
18
Case Study: Duong
Duong, a 23-year-old man is newly diagnosed with HIV• He is clinical stage 1• His initial CD4 count returns at 89
cells/mm3
You perform a TB symptom screen:• He denies fever, cough, sweats, and weight
loss What OIs is he at risk for? What prophylaxis would you start?
Primary Prophylaxis for Select OIs
Disease/ Agent Indication Primary Prophylaxis
When to stop?
Pneumocystis jiroveci
CD4 < 200 or WHO Stage 3
or 4Cotrimoxazole (960mg tab) once daily
CD4 > 200 cells/ml for
more than 6 monthsToxoplasma
gondiiCD4 < 100 or WHO Stage 4
Mycobacterium tuberculosis
Negative TB screening
tests
INH 300 mg daily x 9 months
After treatment
course
20
Secondary Prophylaxis
21
Secondary Prophylaxis of OIs (1)
Also called “Maintenance Therapy” OI medication is continued to prevent
relapse Continued for life or until the patient:• starts ART• has an increase in CD4 count which
persists over a specified period of time
22
Secondary Prophylaxis of OIs (2)
OIs which require secondary prophylaxis include:• PCP• Cerebral toxoplasmosis• Systemic fungal infections• Disseminated MAC infection• CMV disease
23
Secondary Prophylaxis for Select OIs
Disease / Agent
Indication Secondary Prophylaxis
When to stop?
Pneumocystis jiroveci
Prior history of PCP
CTX (960mg) 1 tablet daily
CD4 > 200 cells/ml for more than 6
months
Toxoplasma gondii
Prior history of Toxoplasma encephalitis
Cryptococcus neoformans
Prior history of cryptococcosis
Fluconazole 150-200 mg/day
Penicillium marneffei
Prior history of penicilliosis
Itraconazole 200 mg daily
24
Case Study: Nga
Nga, a 25-year-old woman, presents to your clinic for follow-up of penicillium infection• She is about to complete 10 weeks of intensive
phase treatment (Itraconazole 400 mg/day)• She has recently been started on ART• She is feeling well and wants to know whether
she can stop the Itraconazole at the end of the 10 week course
What should you recommend regarding the Itraconazole?
When can she safely stop it?
25
Key Points
Many OIs can be prevented with the use of primary or secondary
CTP is inexpensive, effective against many OIs, and reduces overall morbidity and mortality
IPT can prevent latent TB from becoming active TB
26
Thank you!
Questions?